HomeCompareKMSTF vs PM

KMSTF vs PM: Dividend Comparison 2026

KMSTF yields 62.31% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMSTF wins by $679.4K in total portfolio value
10 years
KMSTF
KMSTF
● Live price
62.31%
Share price
$3.21
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$729.0K
Annual income
$175,361.30
Full KMSTF calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — KMSTF vs PM

📍 KMSTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKMSTFPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KMSTF + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KMSTF pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KMSTF
Annual income on $10K today (after 15% tax)
$5,295.95/yr
After 10yr DRIP, annual income (after tax)
$149,057.10/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, KMSTF beats the other by $146,938.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KMSTF + PM for your $10,000?

KMSTF: 50%PM: 50%
100% PM50/50100% KMSTF
Portfolio after 10yr
$389.3K
Annual income
$88,926.66/yr
Blended yield
22.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

KMSTF
No analyst data
Altman Z
-328.3
Piotroski
2/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KMSTF buys
0
PM buys
0
No recent congressional trades found for KMSTF or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKMSTFPM
Forward yield62.31%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$729.0K$49.6K
Annual income after 10y$175,361.30$2,492.02
Total dividends collected$608.8K$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: KMSTF vs PM ($10,000, DRIP)

YearKMSTF PortfolioKMSTF Income/yrPM PortfolioPM Income/yrGap
1← crossover$16,931$6,230.53$11,648$408.29+$5.3KKMSTF
2$27,974$9,858.52$13,589$495.90+$14.4KKMSTF
3$45,156$15,223.51$15,877$603.21+$29.3KKMSTF
4$71,283$22,966.14$18,580$734.88+$52.7KKMSTF
5$110,155$33,882.50$21,781$896.75+$88.4KKMSTF
6$166,800$48,934.07$25,578$1,096.12+$141.2KKMSTF
7$247,726$69,249.85$30,092$1,342.17+$217.6KKMSTF
8$361,186$96,119.21$35,470$1,646.46+$325.7KKMSTF
9$517,443$130,974.20$41,892$2,023.58+$475.6KKMSTF
10$729,026$175,361.30$49,578$2,492.02+$679.4KKMSTF

KMSTF vs PM: Complete Analysis 2026

KMSTFStock

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was founded in 2008 and is based in Ness Ziona, Israel.

Full KMSTF Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this KMSTF vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KMSTF vs SCHDKMSTF vs JEPIKMSTF vs OKMSTF vs KOKMSTF vs MAINKMSTF vs MOKMSTF vs BTIKMSTF vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.